We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+0.8%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$796M
AUM Growth
-$185M
Cap. Flow
-$163M
Cap. Flow %
-20.42%
Top 10 Hldgs %
3.37%
Holding
1,987
New
622
Increased
338
Reduced
393
Closed
624

Top Sells

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$5.34M
2
MSFT icon
Microsoft
MSFT
+$5.22M
3
OPLN
Openlane
OPLN
+$4.6M
4
AAPL icon
Apple
AAPL
+$4.51M
5
HRI icon
Herc Holdings
HRI
+$4.09M

Sector Composition

Rank Sector Weight
1 Healthcare 16.45%
2 Industrials 15.7%
3 Technology 14.88%
4 Consumer Discretionary 11.13%
5 Financials 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTUS icon
951
Metallus
MTUS
$898M
$293K 0.04%
17,759
+2,076
+13% +$30.2K
DM
952
DELISTED
Desktop Metal, Inc.
DM
$292K 0.04%
5,894
+4,857
+468% +$327K
AFIB
953
DELISTED
Acutus Medical Inc
AFIB
$292K 0.04%
+85,727
New +$483K
CIM
954
Chimera Investment
CIM
$1B
$291K 0.04%
+6,433
New +$304K
MGA icon
955
Magna International
MGA
$18.8B
$291K 0.04%
+3,599
New +$293K
OMER icon
956
Omeros
OMER
$959M
$291K 0.04%
45,308
-18,462
-29% -$134K
OHI icon
957
Omega Healthcare
OHI
$14.7B
$290K 0.04%
9,814
+865
+10% +$25.3K
ZYXI
958
DELISTED
Zynex
ZYXI
$289K 0.04%
+31,918
New +$354K
SDC
959
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$289K 0.04%
+123,100
New +$514K
MYOV
960
DELISTED
Myovant Sciences Ltd.
MYOV
$289K 0.04%
18,586
+4,330
+30% +$82.7K
NKTX icon
961
Nkarta
NKTX
$172M
$288K 0.04%
+18,747
New +$322K
EME icon
962
Emcor
EME
$36B
$287K 0.04%
+2,255
New +$279K
IWB icon
963
iShares Russell 1000 ETF
IWB
$50.2B
$286K 0.04%
1,082
-271
-20% -$69.8K
OTLK icon
964
Outlook Therapeutics
OTLK
$191M
$286K 0.04%
+10,502
New +$375K
QCOM icon
965
Qualcomm
QCOM
$176B
$286K 0.04%
1,564
-2,534
-62% -$406K
SBS icon
966
Sabesp
SBS
$18.7B
$286K 0.04%
+200,862
New +$261K
SHO icon
967
Sunstone Hotel Investors
SHO
$2.06B
$286K 0.04%
24,381
-29,592
-55% -$354K
HEP
968
DELISTED
Holly Energy Partners, L.P.
HEP
$286K 0.04%
+17,358
New +$308K
GM icon
969
General Motors
GM
$76.8B
$285K 0.04%
4,863
-10,306
-68% -$602K
CHRS icon
970
Coherus Oncology
CHRS
$196M
$284K 0.04%
+17,781
New +$311K
DARE icon
971
Dare Bioscience
DARE
$21M
$284K 0.04%
11,820
+10,816
+1,077% +$223K
GEVO icon
972
Gevo
GEVO
$382M
$284K 0.04%
66,370
+47,243
+247% +$289K
VNDA icon
973
Vanda Pharmaceuticals
VNDA
$302M
$284K 0.04%
+18,092
New +$315K
CHGG icon
974
Chegg
CHGG
$102M
$283K 0.04%
9,224
+3,109
+51% +$126K
CTS icon
975
CTS Corp
CTS
$1.89B
$282K 0.04%
7,668
-2,589
-25% -$90.6K

Similar funds

GSA Capital Partners's Q4 2021 Portfolio in Review

As of Q4 2021, GSA Capital Partners held 1,987 positions worth $796M, down 19% from $982M the previous quarter. Its ten largest holdings account for 3.4% of the portfolio.

GSA Capital Partners withdrew a net $163M in Q4 2021, closing 624 positions and reducing 393 holdings. Its most notable exit was Morgan Stanley, an estimated $5.34M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.

Against the trend, GSA Capital Partners opened a new position in Genius Sports worth $2.45M.

  • GSA Capital Partners's largest Q4 2021 buy was Genius Sports: 322,717 shares worth $2.45M.
  • GSA Capital Partners added most to State Street Consumer Staples Select Sector SPDR ETF in Q4 2021, an estimated $2.43M increase.
  • GSA Capital Partners's biggest Q4 2021 reduction was Microsoft, cutting an estimated $5.22M.
  • GSA Capital Partners fully exited Morgan Stanley in Q4 2021, selling an estimated $5.34M.
  • GSA Capital Partners's ten largest holdings make up 3.4% of its $796M portfolio in Q4 2021.
  • GSA Capital Partners opened 622 new positions and closed 624 in Q4 2021.
  • GSA Capital Partners's portfolio value fell 19% quarter-over-quarter to $796M.

Based on GSA Capital Partners's 13F filing for Q4 2021, filed 14 Feb 2022.